Inactive Instrument

Highlights Covetrus, Inc.

Equities

CVET

US22304C1009

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Covetrus to Showcase Its Vetsuite Solution At VMX 2024	Jan. 10	CI
Covetrus®? Renews Distribution Partnership with National Veterinary Associates	Jan. 04	CI
Covetrus and Vetcor Expand Strategic Partnership with Multi-Year Agreement	23-10-03	CI
Covetrus Expands Greatpetcare Further Unifying Connected Care Solutions for Veterinarians and Pet Parents	23-07-20	CI
Covetrus, Inc. Expands Distribution Across the Southeast U.S., the Caribbean and to U.S. Military Bases Throughout Europe	23-04-25	CI
Covetrus Launches SmartImmune Mushroom to Help Support Powerful Immune Defense in Horses	23-04-05	CI
Newday Veterinary Care At Pet Paradise Selects Covetrus, Inc. Pulse for Its Veterinary Operating System	23-01-10	CI
TPG Capital Partners VIII, L.P. and TPG Healthcare Partners, L.P., managed by TPG Capital, L.P., TPG Global, LLC and Clayton, Dubilier & Rice Fund XI, L.P., managed by Clayton, Dubilier & Rice, LLC completed the acquisition of remaining 75.85% stake in Covetrus, Inc. from a group of shareholders.	22-10-12	CI
Covetrus : Merger Agreement - Form 8-K	22-10-03	PU
Covetrus Q2 Loss Narrows as Net Sales Rise	22-08-04	MT
Earnings Flash (CVET) COVETRUS Posts Q2 Revenue $1.22B	22-08-04	MT
Covetrus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-04	CI
European Commission OKs Acquisition Of Joint Control Of Covetrus	22-07-22	MT
Covetrus Strikes $4 Billion Go-Private Deal With Clayton, Dubilier & Rice, TPG Capital	22-05-25	MT
Covetrus Agrees Take-Private Sale to Clayton, Dubilier & Rice and TPG; Deal Values Company at $4 Billion	22-05-25	MT
Covetrus Says it Gets Proposal From Clayton, Dubilier & Rice, TPG Global to Buy Shares for $21 per Share	22-05-20	MT
TPG Capital Partners VIII, L.P. and TPG Healthcare Partners, L.P., managed by TPG Capital, L.P., TPG Global, LLC and Clayton, Dubilier & Rice Fund XI, L.P., managed by Clayton, Dubilier & Rice, LLC made a non-binding proposal to acquire remaining 75.85% stake in Covetrus, Inc. from a group of shareholders for $2.3 billion.	22-05-19	CI
Covetrus Q1 Loss Narrows, Revenue Grows	22-05-05	MT
Earnings Flash (CVET) COVETRUS Posts Q1 Revenue $1.15B, vs. Street Est of $1.15B	22-05-05	MT
Covetrus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Covetrus, Inc.

Equities

CVET

US22304C1009

Highlights

Filters